The effect of Ding-kun-dan comparing with Marvelon on primary dysmenorrhea

A prospective, double-blind, multicenter, randomized controlled trial

Bibliographic Data

ID14735664
AuthorsJingwen Gan (0009-0007-7821-7639, Chinese Academy of Medical Sciences & Peking Union Medical College), Shi-Yang Zhu (0000-0002-9751-2103), Shiyang Zhu (0009-0000-4165-2599, Chinese Academy of Medical Sciences & Peking Union Medical College), Xiao Ma (0000-0003-1318-3590, Chinese Academy of Medical Sciences & Peking Union Medical College), Xue-song Ding (Peking Union Medical College Hospital), Yan Deng (0000-0002-9056-2554, Peking Union Medical College Hospital), Yanfang Wang (0000-0002-4926-6868, Chinese Academy of Medical Sciences & Peking Union Medical College), Aijun Sun (0000-0003-4830-3249, Chinese Academy of Medical Sciences & Peking Union Medical College, corresponding author), Ai-jun Sun
Year2024
Volume318
IssuePt B
Pages116975
Publication date2024-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2023.116975
PMID37517569
OpenAlexW4385336061
LanguageEN
References cited16

Ding-kun-dan is another available, effective and safe method for patients with primary dysmenorrhea to choose, especially for those who are suffered from mild pain and/or contraindicated to hormonal agents

Adverse effect · Clinical trial · Hormone · Insulin · Insulin resistance · Menstrual cycle · Menstruation · Pill · Polycystic ovary · Randomized controlled trial · Healthcare and Venom Research · Medicine · Menopause: Health Impacts and Treatments · Menstrual Health and Disorders · Internal Medicine

Tools

Open DOIOpen Access